Many pharmaceutical companies have good visibility of business IT systems and formal validated applications, but much less visibility of the operational technology (OT) layer underneath them. Often, organisations rely on automation components that are no longer supported. As support fades, the risk of breakdowns, delays, and security gaps, grows.
